Fig. 10From: Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelActivity per unit mass (Bq/g) in kidneys for free 213Bi (black bar) and 225Ac-DOTA-anti-PD-L1-BC (gray bar) at 1, 6, 24, 72, and 144 h p.i. from a 15-kBq 225Ac-DOTA-anti-PD-L1-BC (3 mg/kg, 60 μg) i.v. injectionBack to article page